Sign in

CIK 0001503802 · Non-accelerated filer<br>Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
263931704
Phone
617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-10-15 Abate Kristin Chief Accounting Officer Grant or award +12,799 22,845
2025-10-15 Poulton Stuart EVP, Chief Development Officer Grant or award +39,682 67,392
2025-10-15 Mano Michael SVP, General Counsel&Secretary Grant or award +43,650 65,075
2025-10-15 Paulson Richard A. President and CEO Grant or award +114,285 198,331
2025-10-15 Cheng Sohanya Roshan EVP & Chief Commercial Officer Grant or award +43,650 79,506
2025-10-15 Macomber Lori EVP, CFO & Treasurer Grant or award +43,650 54,316
2025-10-01 Abate Kristin Chief Accounting Officer Sale −362 $6.30 $2K 10,046
2025-09-15 Paulson Richard A. President and CEO Sale −1,257 $6.43 $8K 84,046
2025-09-15 Mano Michael SVP, General Counsel&Secretary Sale −234 $6.43 $2K 21,425
2025-09-15 Poulton Stuart EVP, Chief Development Officer Sale −401 $6.43 $3K 27,710
2025-09-15 Rangwala Reshma EVP & Chief Medical Officer Sale −408 $6.43 $3K 29,390
2025-09-15 Cheng Sohanya Roshan EVP & Chief Commercial Officer Sale −325 $6.43 $2K 35,856
2025-09-15 Abate Kristin Chief Accounting Officer Sale −23 $6.43 $148 10,408
2025-09-12 Paulson Richard A. President and CEO Grant or award +2,800 85,303
2025-09-12 Mano Michael SVP, General Counsel&Secretary Grant or award +612 21,659
2025-09-12 Poulton Stuart EVP, Chief Development Officer Grant or award +888 28,111
2025-09-12 Rangwala Reshma EVP & Chief Medical Officer Grant or award +945 29,798
2025-09-12 Cheng Sohanya Roshan EVP & Chief Commercial Officer Grant or award +945 36,181
2025-09-12 Abate Kristin Chief Accounting Officer Grant or award +46 10,431
2025-09-03 Abate Kristin Chief Accounting Officer Sale −12 $6.78 $81 9,463

Page 3 of 7 · 138 trades